Corsearch: Turning Trademark Intelligence Into a Front Line Against Pharmaceutical Counterfeiting

Overview: How Corsearch’s AI-Driven Online Brand Protection & Counterfeit Enforcement Platform Transforms Pharmaceutical and Life Sciences Brand Protection

Corsearch is an online brand-protection and counterfeit-enforcement platform that helps pharmaceutical and life sciences organisations identify, investigate, and respond to trademark and brand misuse across digital channels. In an industry where product names, packaging, and trusted digital touchpoints carry significant commercial and patient-safety value, fragmented online monitoring can leave teams reacting late to suspected impersonation, unauthorised listings, and counterfeit-related activity.

The platform brings together trademark intelligence, web-scale data collection, and AI-assisted analysis to make a broad and fast-changing digital landscape more searchable and actionable. By connecting signals from online marketplaces, websites, social platforms, and other public-facing sources, it can help distinguish potentially relevant risks from large volumes of routine online content. This gives teams a more structured basis for investigating suspicious activity and prioritising follow-up work rather than relying exclusively on manual search and disconnected evidence gathering.

For healthcare and life sciences operations, Corsearch can turn brand-protection work from an intermittent, resource-heavy exercise into a more continuous intelligence workflow. Earlier visibility into potential misuse may shorten investigation timelines, while consolidated findings can reduce administrative effort involved in documenting and coordinating responses. The result is stronger decision quality around where to focus enforcement activity and a clearer view of the online threats that can affect established product brands

Last checked on August 25, 2026: Corsearch remains active and is transitioning trademark workflows to TrademarkNow while expanding its AI-native brand-protection platform and IP-enforcement capabilities

What is Corsearch?

Corsearch provides trademark intelligence, pharmaceutical name clearance, and online brand-protection capabilities for life sciences organisations assessing proposed product names and monitoring potential trademark or brand misuse. Its primary use cases include searching and evaluating pharmaceutical naming conflicts, including POCA-related analysis, alongside broader trademark monitoring and digital brand-protection workflows; current Corsearch materials also direct legacy platform users toward TrademarkNow.

The platform is relevant to pharmaceutical and life sciences IP, legal, brand, and product-development teams, not clinical care users. Its differentiators are its trademark-focused data and workflow approach, with current materials describing AI-assisted trademark-clearance capabilities; the platform does not specify regulatory, clinical-evidence, or healthcare compliance claims.

Why Do Leading Healthcare Teams Trust Corsearch?

• Corsearch remains an active provider of trademark intelligence, online brand protection, and IP-enforcement technology; its life-sciences offering covers pharmaceutical naming and trademark-search workflows.

• Corsearch’s pharmaceutical workflow combines trademark, INN, Pharma-in-Use, and POCA information in a single search process, according to its product materials.

• Current Corsearch materials describe NLP-assisted and AI-driven capabilities for trademark search, screening, monitoring, and related brand-intelligence tasks.

• Corsearch reported completing migration of its Online Brand Protection customers to an AI-native platform in 2025, with further platform enhancements planned through 2026.

• Corsearch is transitioning trademark workflow users from its legacy Corsearch Platform to TrademarkNow, which may be relevant to product-continuity and implementation assessments.

• Corsearch acquired the Courtemis IP-enforcement case-management platform from MF Brands in June 2026, adding enforcement-workflow and collaboration capabilities.

• Courtemis was already used by the global IP operations of Lacoste, Gant, Aigle, and Tecnifibre before its acquisition by Corsearch; these are brand-protection rather than healthcare references.

• Corsearch is listed in Cobepa’s 2025 portfolio; the reviewed materials describe Corsearch as held under co-control, although a current ownership breakdown is not specified.

• FDA clearance, CE marking, clinical validation, HIPAA alignment, ISO certifications, and healthcare-specific privacy certifications were not specified in the reviewed live sources.